The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
Review
[키워드] adjusted
administration
age
Anakinra
Analysis
association
baseline
C-reactive protein
clinical benefit
conducted
confidence interval
confounders
COVID-19
COVID-19 therapeutics
death
Effect
eligible
Evidence
hazard ratio
hospitalized patient
hyperinflammation
Immunomodulatory agent
Immunomodulatory treatment
inclusion criteria
inhibitor
Intubated
males
men
Meta-analysis
meta-regression
Mortality
non-randomized
observational studies
offer
outcome
patients treated
patients with COVID-19
patients with moderate
Randomized
review
Risk of bias
risk of death
selected
severe pneumonia
shown
Support
symptoms onset
systematic review
the mean
treated
Treatment
updated
was performed
with COVID-19
[DOI] 10.3390/jcm10194462 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10194462 PMC 바로가기 [Article Type] Review